• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

ANI Pharma(ANIP.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Barclays Upgrades ANI Pharmaceuticals to Outperform
16:08
Nov15
ANI Pharmaceuticals Executives Sell Shares and Report Strong Earnings
02:12
Nov7
ANI Pharma released FY2025 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 227.81 M (forecast USD 212.85 M), actual EPS USD 1.133 (forecast USD 0.36)
14:30
ANI Pharma released FY2025 9 Months Earnings on November 7 Pre-Market EST, with actual revenue of USD 636.31 M and EPS of USD 2.1799
14:30
Oct31
ANI Pharma to release FY2025 Q3 earnings report on November 7 During-Market EST, forecast revenue USD 212.85 M, EPS USD 0.36
00:14
Oct15
Analyst Khurshid Recommends BUY Rating on ANI Pharmaceuticals Stock
15:37

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 227.81 M, Net Income 23.79 M, EPS 1.133

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 211.37 M, Net Income 7.323 M, EPS 0.3614

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.12 M, Net Income 13.71 M, EPS 0.6855

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.616
+183.32%
+7.510
ANGH
3.890
+67.68%
+1.570
ESHA
22.044
+53.29%
+7.664
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2852
+47.01%
+0.092
SIDU
3.585
+34.27%
+0.915
RDACR
0.2493
+31.21%
+0.059
ORIS
1.550
+27.05%
+0.330
VNDA
8.910
+26.74%
+1.889
ULY
3.420
+23.92%
+0.680
View More